# HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol

> **NCT00000799** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 100 (—)

## Conditions studied

- Cytomegalovirus Retinitis
- HIV Infections

## Interventions

- **DRUG:** Cidofovir
- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT00000799
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1996-04
- **Target enrollment:** 100 (—)
- **Last updated:** 2012-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000799, "HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00000799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*